La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
HCA Healthcare Gestione
Gestione criteri di controllo 2/4
HCA Healthcare's Il CEO è Sam Hazen, nominato in Jan2019, e ha un mandato di 5.58 anni. la retribuzione annua totale è $ 21.32M, composta da 7.1% di stipendio e 92.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.51% delle azioni della società, per un valore di $ 497.34M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 8.5 anni.
Informazioni chiave
Sam Hazen
Amministratore delegato
US$21.3m
Compenso totale
| Percentuale dello stipendio del CEO | 7.1% |
| Mandato del CEO | 5.6yrs |
| Proprietà del CEO | 0.5% |
| Durata media del management | 5.6yrs |
| Durata media del Consiglio di amministrazione | 8.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 26
Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?
Jun 21HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable
Jun 06Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
May 21HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 30Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong
Apr 11HCA Healthcare Is Finally At Fair Value (Rating Downgrade)
Mar 19HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)
Feb 29HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66
Feb 25HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year
Feb 05HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jan 21At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Jan 08HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings
Dec 25HCA Healthcare Continues To Impress
Dec 14Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?
Dec 11HCA Remains Attractive Despite A JV Misstep
Nov 20These 4 Measures Indicate That HCA Healthcare (NYSE:HCA) Is Using Debt Extensively
Oct 26HCA Healthcare: Rx For Success
Oct 10A Look Into HCA Healthcare's (NYSE:HCA) Impressive Returns On Capital
Oct 09HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift
Sep 30At US$256, Is It Time To Put HCA Healthcare, Inc. (NYSE:HCA) On Your Watch List?
Sep 17HCA Healthcare Is Beating The Industry
Sep 13Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly
Jul 25HCA Healthcare (NYSE:HCA) Is Aiming To Keep Up Its Impressive Returns
Jul 10HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth
Jul 03HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 45% Above Its Share Price
Jun 25Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?
Jun 09HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09HCA Healthcare (NYSE:HCA) Has Announced That It Will Be Increasing Its Dividend To $0.60
May 25HCA Healthcare (NYSE:HCA) Has A Pretty Healthy Balance Sheet
Apr 22HCA Healthcare (NYSE:HCA) Knows How To Allocate Capital
Apr 04Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 45%?
Mar 16At US$249, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Feb 26HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jan 30HCA Healthcare Q4 2022 Earnings Preview
Jan 26HCA Healthcare: An Investment For Interesting Times
Jan 13Investors Shouldn't Overlook The Favourable Returns On Capital At HCA Healthcare (NYSE:HCA)
Jan 04Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$6b |
| Mar 31 2024 | n/a | n/a | US$5b |
| Dec 31 2023 | US$21m | US$2m | US$5b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$6b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$15m | US$2m | US$6b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$7b |
| Dec 31 2021 | US$21m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$5b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$30m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$27m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$10m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$3b |
| Jun 30 2018 | n/a | n/a | US$3b |
| Mar 31 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$10m | US$1m | US$2b |
Compensazione vs Mercato: La retribuzione totale di Sam ($USD 21.32M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 13.17M ).
Compensazione vs guadagni: La retribuzione di Sam è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Sam Hazen (64 yo)
5.6yrs
Mandato
US$21,315,984
Compensazione
Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 5.6yrs | US$21.32m | 0.51% $ 520.5m | |
| Executive VP & COO | 1.6yrs | US$8.70m | 0.066% $ 66.5m | |
| President of American Group | 11.6yrs | US$5.40m | 0.047% $ 47.3m | |
| President of National Group | 8.1yrs | US$5.58m | 0.010% $ 10.6m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.19% $ 188.1m | |
| CFO & Executive Vice President | less than a year | Nessun dato | 0.027% $ 27.4m | |
| Senior VP | 8.3yrs | Nessun dato | 0.016% $ 15.9m | |
| Senior VP & Chief Information Officer | less than a year | Nessun dato | 0.00061% $ 618.3k | |
| Executive VP and Chief Legal & Administrative Officer | 2.6yrs | US$6.47m | 0.0016% $ 1.6m | |
| Vice President of Investor Relations | 2.6yrs | Nessun dato | Nessun dato | |
| Senior VP and Chief Ethics & Compliance Officer | 5.6yrs | Nessun dato | 0.0037% $ 3.7m | |
| Senior Vice President of Marketing & Corporate Affairs | 6.8yrs | Nessun dato | 0.0014% $ 1.4m |
5.6yrs
Durata media
60yo
Età media
Gestione esperta: Il team dirigenziale di HCA è esperto e expertise (durata media dell'incarico 5.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 5.9yrs | US$21.32m | 0.51% $ 520.5m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.19% $ 188.1m | |
| Independent Director | 6.6yrs | US$389.78k | 0% $ 0 | |
| Independent Director | 10.5yrs | US$377.95k | 0.0016% $ 1.6m | |
| Independent Director | 10.5yrs | US$334.78k | 0.0078% $ 7.9m | |
| Chairman of the Board | 18.6yrs | US$399.61k | Nessun dato | |
| Independent Director | 5.4yrs | US$319.78k | 0.0024% $ 2.5m | |
| Independent Director | 2.9yrs | US$339.78k | 0.0010% $ 1.0m | |
| Independent Director | 12.6yrs | US$349.78k | 0.0042% $ 4.2m | |
| Director | 15.6yrs | US$309.70k | 0.16% $ 159.4m | |
| Independent Director | 2.6yrs | US$324.78k | 0.0014% $ 1.4m | |
| Director of HealthONE | no data | Nessun dato | Nessun dato |
8.5yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HCA sono considerati esperti (durata media dell'incarico 8.5 anni).